Innfocus (Miami) reported raising $32.8 million in a Series C funding round. The firm is one of several competing companies Medical Device Daily has dubbed the MIGS-6, in the minimally invasive glaucoma surgical space. The group has been highly active within the past few months, with activity that ranges from clinical trial completions to initial public offerings.